GUARINO, MICHELE PIER LUCA
 Distribuzione geografica
Continente #
AS - Asia 6.735
NA - Nord America 1.104
EU - Europa 580
SA - Sud America 94
AF - Africa 20
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.553
Nazione #
SG - Singapore 5.639
US - Stati Uniti d'America 1.054
CN - Cina 581
HK - Hong Kong 344
IT - Italia 181
GB - Regno Unito 157
DE - Germania 79
BR - Brasile 74
VN - Vietnam 60
NL - Olanda 31
CA - Canada 27
IN - India 26
JP - Giappone 24
FI - Finlandia 22
AU - Australia 19
ID - Indonesia 17
CZ - Repubblica Ceca 16
SE - Svezia 13
MX - Messico 12
FR - Francia 11
PL - Polonia 11
ZA - Sudafrica 11
UA - Ucraina 10
TR - Turchia 9
AR - Argentina 8
ES - Italia 8
RU - Federazione Russa 8
BD - Bangladesh 6
AT - Austria 5
GR - Grecia 5
IR - Iran 5
BE - Belgio 4
PH - Filippine 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
CH - Svizzera 3
CO - Colombia 3
EG - Egitto 3
PY - Paraguay 3
AZ - Azerbaigian 2
CL - Cile 2
DM - Dominica 2
EC - Ecuador 2
IQ - Iraq 2
KR - Corea 2
LT - Lituania 2
MY - Malesia 2
PK - Pakistan 2
SD - Sudan 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GD - Grenada 1
GI - Gibilterra 1
HU - Ungheria 1
IM - Isola di Man 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
LC - Santa Lucia 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MS - Montserrat 1
NA - Namibia 1
PE - Perù 1
PR - Porto Rico 1
SA - Arabia Saudita 1
SI - Slovenia 1
SN - Senegal 1
Totale 8.553
Città #
Singapore 429
Hong Kong 332
Ashburn 261
Hefei 246
Boardman 145
London 145
Beijing 122
Shanghai 91
Dallas 84
Rome 74
Council Bluffs 50
Los Angeles 42
Munich 38
West Jordan 34
San Francisco 31
Santa Clara 30
Washington 26
Amsterdam 24
Ho Chi Minh City 23
Sona 18
Seattle 15
São Paulo 15
Pune 13
Tokyo 12
Turku 12
Brno 11
Charlotte 11
New York 11
Toronto 11
Boston 10
Canberra 10
Chicago 10
Hanoi 10
Helsinki 10
Mexico City 10
Warsaw 10
Brooklyn 9
Stockholm 7
Boydton 6
Johannesburg 6
Phoenix 6
Athens 5
Borås 5
Buffalo 5
Guiyang 5
Melbourne 5
Olomouc 5
Paris 5
Atlanta 4
Denver 4
Frankfurt am Main 4
Guangzhou 4
Milan 4
Montreal 4
Nagoya 4
Naples 4
Providence 4
Rimini 4
Aprilia 3
Chengdu 3
Ferrara di Monte Baldo 3
Hanover 3
Jakarta 3
Kanazawa 3
Markham 3
Nuremberg 3
San Mateo 3
Secaucus 3
The Dalles 3
Volla 3
Ajman 2
Albignasego 2
Ankara 2
Bangkok 2
Bari 2
Berlin 2
Bogotá 2
Bratislava 2
Brookline 2
Brussels 2
Carney 2
Central 2
Changsha 2
Chongqing 2
Da Nang 2
Damietta 2
Dhaka 2
Fortaleza 2
Galatone 2
Gangnam-gu 2
Haiphong 2
Jackson 2
Jinan 2
Kuala Lumpur 2
Lamezia Terme 2
Linz 2
Manchester 2
Messina 2
New Delhi 2
Oklahoma City 2
Totale 2.631
Nome #
Capitolo: Sindrome dell'intestino irritabile. 227
Constipation-Predominant Irritable Bowel Syndrome (IBS-C): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms 221
Dilated intercellular spaces of esophageal epithelium in nonerosive reflux disease patients with physiological esophageal acid exposure 217
ANTIOXIDANT ACTIVITY OF INULIN AND ITS ABILITY TO PREVENT HUMAN COLONIC MUSCLE CELL IMPAIRMENT INDUCED BY LIPOPOLYSACCHARIDE MUCOSAL EXPOSURE 213
Effect of hypothermia on human colonic smooth muscle contractility 211
Early impairment of food intake in patients newly diagnosed with cancer 204
Colonic Epithelial Permeability to Ions Is Restored after Vedolizumab Treatment and May Predict Clinical Response in Inflammatory Bowel Disease Patients 204
A case of hepatitis B virus infection in Eritrean Diciotti migrant: phylogenetic analysis and 'mirror effect' 203
Chronic pain in irritable bowel syndrome and other comorbid pain conditions 202
Colonic mucosa exposure to pathogenic lipopolysaccharide induces impairment of smooth muscle cells contraction 202
Sarcopenia Does Not Impact the Outcome of Patients with Multiple Myeloma Consolidated with Autologous Hematopoietic Stem Cell Transplantation 198
EFFECTS OF THERMAL COOLING ON HUMAN COLONIC SMOOTH MUSCLE CONTRACTILITY 197
DECREASED NUMBER OF ACTIVATED MACROPHAGES IN GALLBLADDER MUSCLE LAYER OF CHOLESTEROL GALLSTONES PATIENTS FOLLOWUING URSODEOXYCHOLIC ACID 194
Impaired Human Colonic Contractility and Toll-Like Receptor 4 (TLR4) Expression in Uncomplicated Diverticular Disease 193
Effect of oesophagitis on proximal extent of gastro-oesophageal reflux. 190
Impairment of GH/IGF-1 Axis in the liver of patients with hcv-related chronic hepatitis 190
Betacoronaviruses genome analysis reveals evolution toward specific codons usage: Implications for SARS-CoV-2 mitigation strategies 189
IMPAIRED HUMAN COLONIC CONTRACTILITY AND TOLL-LIKE RECEPTOR 4 (TLR4) EXPRESSION IN UNCOMPLICATED DIVERTICULAR DISEASE 188
Leonardo da Vinci's advice on public health. 188
Origin and evolutionary dynamics of Hepatitis B virus (HBV) genotype E in Madagascar 151
Activated muscularis macrophages contribute to muscle cell dysfunction in cholesterol gallstone patients 114
Association between dietary habits and fecal microbiota composition in irritable bowel syndrome patients: A pilot study 111
Gut Microbiota and Related Electronic Multisensorial System Changes in Subjects With Symptomatic Uncomplicated Diverticular Disease Undergoing Rifaximin Therapy 109
Effect of acute mucosal exposure to Lactobacillus rhamnosus GG on human colonic smooth muscle cells 105
Hepatitis C virus genotype 3A in a population of injecting drug users in Montenegro: Bayesian and evolutionary analysis 104
DOMINO trial post hoc analysis: evaluation of the diet effects on symptoms in IBS subtypes 102
Acid reflux episodes sensitize the esophagus to perception of weakly acidic and mixed reflux in non-erosive reflux disease patients 100
Decreased number of activated macrophages in gallbladder muscle layer of cholesterol gallstone patients following ursodeoxycholic acid 98
Effect of Inulin on Proteome Changes Induced by Pathogenic Lipopolysaccharide in Human Colon 98
Asymptomatic parasitic infection in a Crohn's disease patient on anti-TNFα therapy: an alert for our patients? 97
Computer fluid dynamics of post-prandial gallbladder bile flow in gallstone patients: effect of short-term therapy with ursodeossicolic acid 97
Mathematical Modeling of Vedolizumab Treatment’s Effect on Microbiota and Intestinal Permeability in Inflammatory Bowel Disease Patients 97
Effect of endoscopic augmentation of the lower oesophageal sphincter (Gatekeeper reflux repair system) on intraoesophageal dynamic characteristics of acid reflux 96
Esophageal disease: updated information on inflammation 93
Gastrointestinal sensitivity and gastroesophageal reflux disease 93
Chemokines and Inflammatory Mediators in Erosive Esophagitis (EE) Compared to Non-Erosive Reflux Disease (NERD) and Control Patients 93
LPS AND RADIATION-INDUCED GUT PERMEABILITY DAMAGE: FOCUS ON THE POTENTIAL BENEFICIAL EFFECT OF GRAPE SEED EXTRACT 90
Leonardo's folio 730 recto: lessons for the medical humanities 89
Effect of hiatal hernia on proximal oesophageal acid clearance in gastro-oesophageal reflux disease patients 86
Experimental evidence and mathematical modeling of thermal effects on human colonic smooth muscle contractility 83
Antioxidant activity of Inulin and its role in the prevention of human colonic muscle cell impairment induced by Lipopolysaccharide mucosal exposure 82
Gastro-esophageal reflux disease and Obesity, where is the link? 71
Gastroesophageal reflux disease: Update on inflammation and symptom perception 71
Dilated intercellular spaces and acid reflux at the distal and proximal oesophagus in patients with non-erosive gastro-oesophageal reflux disease 68
Human colonic myogenic dysfunction induced by mucosal lipopolysaccharide translocation and oxidative stress 68
Impaired colonic contractility and intestinal permeability in symptomatic uncomplicated diverticular disease 66
Assessment of core and support functions of the communicable disease surveillance system in the Kurdistan Region of Iraq 63
Diarrhea predominant-irritable bowel syndrome (Ibs-d): Effects of different nutritional patterns on intestinal dysbiosis and symptoms 59
Mechanisms of action of prebiotics and their effects on gastro-intestinal disorders in adults 57
Palmitic acid affects intestinal epithelial barrier integrity and permeability in vitro 47
Proximal esophageal extent of acid reflux discriminates non-erosive reflux disease patients with normal from those with pathological pH-metric profile and from healthy subjects 45
Nutritional status and bioelectrical phase angle assessment in adult Crohn disease patients receiving anti-TNFα therapy 42
Protective Role of Natural Compounds under Radiation-Induced Injury 40
Natural Compounds with Antimicrobial Activities in Oral Candida Infections during Head and Neck Radiotherapy 38
Lactobacillus rhamnosus protects human colonic muscle from pathogen lipopolysaccharide-induced damage. 38
The Results From Up-Front Esophageal Testing Predict Proton Pump Inhibitor Response in Patients With Chronic Cough 37
Effect of short-time treatment with ursodeoxicolic acid on postprandial gallbladder bile flow in gallstone patients: a statistical -mathematical analysis of ultrasonographic data 36
Exploring the genetic diversity of the 16S rRNA gene of Akkermansia muciniphila in IBD and IBS 35
Intra-oesophageal distribution and perception of acid reflux in patients with non-erosive gastro-oesophageal reflux disease 34
Phylogenetic analysis of Prevotella copri from fecal and mucosal microbiota of IBS and IBD patients 33
Ultrasonographic assessment of gallbladder bile exchanges in healthy subjects and in gallstone patients 33
Increased TRPV1 gene expression in esophageal mucosa of patients with non-erosive and erosive reflux disease 33
Ursodeoxycholic acid improves muscle contractility and inflammation in symptomatic gallbladders with cholesterol gallstones 32
Impact of Weight Loss on Surgical Outcomes in Resectable Pancreatic Cancer Patients Undergoing Pancreaticoduodenectomy (PD) 32
Impared human colonic contractility and Toll-like receptor 4 (tlr4) expression in uncomplicated diverticular disease 32
Effect of pathogenetic lipopolysaccharide translocation on human colonic smooth muscle cell contraction and Toll-Like 4 Receptor expression 31
MICROBIOTA E MOTILITA' INTESTINALE 31
Impaired contractility of colonic muscle cells in a patient with chronic intestinal pseudo-obstruction 31
HCl-induced and ATP-dependent upregulation of TRPV1 receptor expression and cytokine production by human esophageal epithelial cells 30
ULTRASONOGRAPHIC ASSESSMENT OF GALLBLADDER (GB) BILE TURNOVER BEST INDICATES THE DEFECTIVE GB EFFICIENCY IN GALLSTONES PATIENTS 30
Gut Microbiota and COVID-19: Potential Implications for Disease Severity 29
Fecal and Mucosal Microbiota Profiling in Irritable Bowel Syndrome and Inflammatory Bowel Disease 29
Weak peristalsis with large breaks is associated with higher acid exposure and delayed reflux clearance in the supine position in GERD patients 29
Ursodeoxycholic acid therapy in gallbladder disease, a story not yet completed 29
Supernatants of irritable bowel syndrome mucosal biopsies impair human colonic smooth muscle contractility 29
Human Colonic Smooth Muscle Contractility Following Acute Thermal Cooling 29
Starring role of toll-like receptor-4 activation in the gut-liver axis. 29
The Origins of NAFLD: The Potential Implication of Intrauterine Life and Early Postnatal Period 29
While we are discussing… the SARS-CoV-2 virus laughs 29
PD-L1/PD-1 check-point in gastric carcinoma with lymphoid stroma case report with immunochemical study 28
Nutritional aspects in inflammatory bowel diseases 28
Gut microbiota dysbiosis as risk and premorbid factors of IBD and IBS along the childhood-adulthood transition 28
Chronic Gastrointestinal Disorders and miRNA-Associated Disease: An Up-to-Date 27
Platelet-activating factor and distinct chemokines are elevated in mucosal biopsies of erosive compared with non-erosive reflux disease patients and controls 27
Patologia funzionale delle vie biliari 27
Effect of ursodeoxycholic acid on inflammatory infiltrate in gallbladder muscle of cholesterol gallstone patients 27
Is it likely that intraabdominal fat is a risk marker of GERD, BE, and adenocarcinoma? What are the means by which obesity may (also) promote carcinogenesis in BE patients? 27
Role of oxidative stress and prostaglandins on colonic muscle cell damage induced by exposure of human mucosa to a pathogenetic lipopolysaccharide 27
ULTRASONOGRAPHIC ASSESSMNENT OF GALLBLADDER BILE EXCHANGES IN HEALTHY SUBJECTS AND IN GALLSTONES PATIENTS 26
La contaminazione batterica intestinale (SIBO) e l'utilità della rifaximina 26
PATTERNS OF GALLBLADDER MOTILITY AND TURNOVER OF GALLBLADDER BILE IN GALLSTONE PATIENTS AND IN HEALTHY SUBJECTS 26
Statistical-mathematical analysis of post-prandial gallbladder volumes and computer-simulated bile flow in gallstone patients treated with ursodeossicolic acid 26
PRE-OPERATIVE ASSESSMENT OF PATIENTS WITH GASTROESOPHAGEAL REFLUX: HOW TO SELECT CANDIDATES FOR SURGERY 26
Exploring the Interplay between COVID-19 and Gut Health: The Potential Role of Prebiotics and Probiotics in Immune Support 25
Role of Overweight and Obesity in Gastrointestinal Disease 25
Gastrointestinal neuromuscular apparatus: an underestimated target of gut microbiota 25
Effect of human colonic mucosa exposure to Lactobacillus GG on smooth muscle cells 25
The Role of Dietary Fibers in the Management of IBD Symptoms 24
Post-reflux swallow-induced peristaltic wave index and mean nocturnal baseline impedance predict PPI response in GERD patients with extra esophageal symptoms 24
Gut mucosal-associated microbiota better discloses inflammatory bowel disease differential patterns than faecal microbiota 24
Totale 8.091
Categoria #
all - tutte 57.912
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.912


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022203 0 1 4 0 6 0 0 4 10 5 5 168
2022/202388 10 0 6 8 5 2 1 2 5 0 49 0
2023/2024553 29 43 27 28 51 230 8 38 3 45 35 16
2024/20256.527 64 65 205 32 100 121 107 13 323 399 2.365 2.733
2025/20261.234 388 239 161 339 107 0 0 0 0 0 0 0
Totale 8.605